RESEARCH ON THE CORRELATION BETWEEN SERUM PEPSINOGEN LEVELS AND GASTRIC MUCOSA HISTOLOGY
Main Article Content
Abstract
Material and methods: A cross-sectional study was conducted in DakLak from March 2015 to June 2018 with 130 patients at the age from 18 years and over who were histopathologically diagnosed with chronic gastritis. All patients underwent gastroscopy, biopsy for histopathological diagnosis, and serum pepsinogen I and II testing. Results: The mean level of PGI was 57.43 ± 34.36 ng/ml, PGII was 15.83 ± 8.31 ng/ml. The level of PGI in the group with intestinal metaplasia was 85.81 ± 71.34 ng/ml, which was higher than the group without intestinal metaplasia 55.07 ± 28.26 ng/ml with p < 0.001. The level of PGI and PG I/II tended to decrease according to the level of atrophic gastritis on histopathology, however, there was no statistically difference with p > 0.05. The level of PG I/II in the active inflammation group was 3.82 ± 1.32, inactive inflammation was 3.84 ± 1.37 and there was no statistically significant difference with P> 0.05. No statistical correlation was found between the level of active inflammation with age and gender. Conclusion: The mean level of PGI and PG I/II ratio tend to decrease inversely with the level of atrophic inflammation; PG I concentration in the group with intestinal metaplasia was higher than the group without intestinal metaplasia (P<0.01). There was no statistical association between active gastritis and PG I concentration and PG I/II ratio. The threshold for PG I/II ratio in patients with severe atrophy is 3.2 ± 0.71, higher than the Japanese PG I/II threshold of < 3.
Article Details
Keywords
Atrophic gastritis, serum pepsinogen
References
2. Graham D. Y., Nurgalieva Z. Z., El-Zimaity H. M., et al (2006). Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clinical gastroenterology and hepatology, 4(3):306-314.
3. Daugule I., Sudraba A., Chiu H. M., et al (2011). Gastric plasma biomarkers and Operative Link Aor Gastritis Assessment gastritis stage. European journal of gastroenterology & hepatology, 23(4):302-307.
4. Miki K., Morita M., Sasajima M., et al (2003). UseAulness oA gastric cancer screening using the serum pepsinogen test method. The American journal of gastroenterology, 98(4):735-739.
5. Dixon M. F., Path F. R. C., Genta R. M., et al. (1996). Classification and grading of gastritis: the updated Sydney system. American Journal of Surgical Pathology. 20(10): 1161-81.
6. Lê Quang Tâm, Bùi Hữu Hoàng (2012). Viêm loét DDTT và nhiễm Helicobacter Pylori ở BN dân tộc Ê Đê tại Bệnh viện tỉnh Đắk Lắk. Tạp chí Y học TP. Hồ Chí Minh. 16(2): 58-67.
7. Quach D. T., Le H. M., Hiyama T., et al (2013). Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter, 18(2):151-157.
8. Wang X., Lu B., Meng L., et al )2-17). The correlation between histological gastritis staging- ‘OLGA/OLGIM’ and serum pepsinogen test in assessment oA gastric atrophy/intestinal metaplasia in China. Scandinavian journal of gastroenterology, 52(8):822-827.
9. Trịnh Tuấn Dũng, Mai Hồng Bàng, Tạ Long và cộng sự (2012). Nghiên cứu mối liên quan nồng độ Pepsinogen, gastrin huyết thanh và tổn thương mô bệnh học viêm dạ dày mạn. Tạp chí Y học thành phố Hồ Chí Minh, 16(2):178 – 183.
10. Vũ Thị Duyên, Vũ Trường Khanh (2020). Nghiên cứu nồng độ pepsinogen huyết thanh ở bệnh nhân viêm teo niêm mạc dạ dày trên nội soi theo phân loại Kimura - Katemoto. Tạp chí Khoa học Tiêu hóa Việt Nam, 58:3574-3578.